Schedule of Related Party Transactions (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
|
| Defined Benefit Plan Disclosure [Line Items] | |||||
| Total Assets | $ 771,047 | $ 771,047 | $ 1,014,551 | ||
| Total Liabilities | 4,593,397 | 4,593,397 | 4,407,512 | ||
| Stockholders’ Equity | (3,392,961) | ||||
| Income | (11,533) | $ (95,633) | (45,576) | $ (190,954) | |
| Expenses | (195,894) | (89,557) | (383,813) | (177,409) | |
| Net Income (Loss) | (207,427) | $ (185,190) | (429,389) | (368,363) | |
| EZFill Holdings, Inc, [Member] | |||||
| Defined Benefit Plan Disclosure [Line Items] | |||||
| Total Assets | 20,709,349 | 20,709,349 | 22,924,118 | ||
| Total Liabilities | 5,121,831 | 5,121,831 | 1,055,672 | ||
| Stockholders’ Equity | 15,687,518 | 15,687,518 | 21,868,446 | ||
| Income | 6,094,499 | 3,372,417 | |||
| Expenses | 13,233,679 | 6,728,507 | |||
| Net Income (Loss) | (7,139,180) | $ (3,356,090) | |||
| Pharmacy No, 27 Ltd [Member] | |||||
| Defined Benefit Plan Disclosure [Line Items] | |||||
| Total Assets | 288,360 | 288,360 | 200,474 | ||
| Total Liabilities | 245,461 | 245,461 | 137,459 | ||
| Stockholders’ Equity | $ 42,899 | $ 42,899 | $ 63,015 | ||
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|